Imbio PHA (4.0.0) vs Steth IO
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your clinical workflow requires automated, quantitative analysis of cardiac structures from CT pulmonary angiogram (CTPA) scans. This tool is ideal for radiologists and cardiologists seeking to efficiently assess right ventricular dilation and risk stratify patients for pulmonary embolism or hypertension based on existing imaging data. It streamlines the interpretation of complex CTPA studies by providing rapid, AI-powered measurements and reports.
View Imbio PHA (4.0.0) →Choose Steth IO if…
Choose Steth IO if you need a portable, digital solution for real-time auscultation that integrates with telemedicine and remote patient monitoring workflows. This smartphone-powered stethoscope is best suited for healthcare providers who wish to visualize, record, and securely share heart and lung sounds, enhancing diagnostic accuracy and facilitating consultations with specialists from any location. It empowers remote care by bringing advanced auscultation capabilities directly to a mobile device.
View Steth IO →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Steth IO |
|---|---|---|
| Pricing | Unknown | Customized pricing; subscription-based for steth io spot. |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud-based |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA is designed for seamless integration into existing radiology DICOM workflows, offering rapid, fully-automated assessments that minimize user intervention and training. Steth IO, while mobile, requires active user engagement with a physical device and app, which can introduce a different learning curve.
Clinical Value
Imbio PHA (4.0.0)Both tools are FDA-cleared, but Imbio PHA provides automated, objective, quantitative measurements (RV/LV, PA/Ao ratios) from CTPA scans, directly aiding in the diagnosis and risk stratification of critical conditions like pulmonary embolism and hypertension. Steth IO enhances traditional auscultation with digital capabilities, but the diagnostic interpretation still relies heavily on the clinician, making Imbio PHA's output more directly actionable for specific diagnoses.
Pricing & Value
Steth IOSteth IO offers greater pricing transparency with a clear subscription-based model for individual users ($15/month for Steth IO Spot) and customized options for clinics. Imbio PHA's 'contact for pricing' approach suggests higher, enterprise-level costs and less upfront transparency, making Steth IO's value proposition more accessible and understandable.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA explicitly offers cloud, enterprise (on-premise), or partner deployment options and is third-party HIPAA certified by Compliancy Group, with a BAA implied. Its integration with native DICOM tools is crucial for hospital imaging infrastructure. Steth IO's HIPAA compliance statement, noting 'user responsible for compliance' and a 'HIPAA warning for email export,' indicates a less robust enterprise-level compliance and integration strategy.
Innovation
TieBoth tools demonstrate significant innovation. Imbio PHA leverages advanced AI for automated, quantitative analysis of complex medical images, providing precise diagnostic insights. Steth IO innovatively transforms a common smartphone into an FDA-cleared diagnostic stethoscope, integrating real-time visualization, recording, and telemedicine capabilities to enhance a fundamental clinical practice and enable remote care.
Support & Docs
Steth IOSteth IO's website provides a dedicated 'Support' section, FAQs, and 'How it Works' videos, offering more readily accessible self-service resources for users. Imbio PHA's support information is less publicly available, primarily directing users to contact them directly for assistance.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Steth IO |
|---|---|---|
| Name | Imbio PHA (4.0.0) | Steth IO |
| Company | Imbio | STRATOSCIENTIFIC |
| Description | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | FDA-cleared smartphone stethoscope that transforms a mobile device into a powerful diagnostic aid. It enables healthcare providers to hear, visualize, record, and share heart and lung sounds in real-time, enhancing diagnostic accuracy and facilitating advanced telemedicine and remote patient monitoring for comprehensive patient care. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Steth IO.